AKEBIA THERAPEUTICS, INC. (AKBA) Capital expenditures 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$291,000FY2025 · since FY2016: $2.7M → $291,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $291,000 | +781.8% |
| FY2024 | $33,000 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $114,000 | +93.2% |
| FY2021 | $59,000 | -81.4% |
| FY2020 | $317,000 | -95.2% |
| FY2019 | $6.7M | +314.4% |
| FY2018 | $1.6M | -1.0% |
| FY2017 | $1.6M | -39.1% |
| FY2016 | $2.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice